Here’s some of HealthDay’s top stories for Monday, Aug. 2: Acne more than a teenage plague. It brings to mind adolescents with pimples fueled by surging hormones, but new research shows bad skin takes a huge emotional toll on grown women, both personally and professionally. Read more An ALS drugContinue Reading

Here’s some of HealthDay’s top stories for Friday, July 30: New data details Delta variant’s dangers. Fresh evidence shows the vaccinated may be spreading the variant as easily as the unvaccinated. The research was what prompted the U.S. Centers for Disease Control and Prevention to reverse its mask guidance forContinue Reading

Here’s some of HealthDay’s top stories for Thursday, July 29: Biden to mandate ‘vaccine or testing’ for federal workers. Faced with tough resistance by many Americans to COVID vaccination and a surge in cases driven by the Delta variant, President Joe Biden on Thursday will issue mandatory vaccination or weeklyContinue Reading

THURSDAY, July 29, 2021 (HealthDay News) — McCormick & Co. on Wednesday announced the recall of several of its popular seasonings because of potential salmonella contamination. Included in the recall are McCormick Perfect Pinch Italian Seasoning, McCormick Culinary Italian Seasoning and Frank’s RedHot Buffalo Ranch Seasoning. The products were shippedContinue Reading

Here’s some of HealthDay’s top stories for Wednesday, July 28: FDA advisor who panned new Alzheimer’s drug speaks out. Dr. G. Caleb Alexander was one of 10 advisors on an 11-member FDA panel who voted against approval of the controversial new Alzheimer’s drug, Aduhelm. The agency approved the drug anyway.Continue Reading

WEDNESDAY, July 28, 2021 (HealthDay News) — Trusting science is good, but it could put you at risk for being duped by false science, or “pseudoscience,” if you let your guard down, researchers warn. Investigators found that people who trust science are more likely to believe and share false claimsContinue Reading

TUESDAY, July 27, 2021 (HealthDay News) — There’s been a sharp rise in schizophrenia cases linked with marijuana use since the mid-1990s, a new Danish study finds. Prior research has suggested that marijuana — particularly very heavy use — is associated with an increased risk of schizophrenia. Although strict cause-and-effectContinue Reading

Here’s some of HealthDay’s top stories for Tuesday, July 27: Choosing the best blood pressure drug for you. A study involving data on more than 3 million people focused on two major classes of drugs used to lower high blood pressure — ACE inhibitors and angiotensin receptor blockers (ARBs). DependingContinue Reading

TUESDAY, July 27, 2021 (HealthDay News) — Watch videos on TikTok and you’re likely to see plenty of positive portrayals of vaping, a new study shows. And that’s a problem, according to researchers, who call for tighter regulation of the platform popular with kids and teens. “Viewing other young people,Continue Reading

Here’s some of HealthDay’s top stories for Monday, July 26: Fauci pushes plan to help prevent future pandemics. America’s leading infectious disease expert, Dr. Anthony Fauci, is proposing an ambitious new research plan aimed at readying vaccines against possible pathogens from 20 families of viruses that could harm humans. TheContinue Reading

Here’s some of HealthDay’s top stories for Friday, July 23: Arguing for & against approval of controversial Alzheimer’s drug. The FDA earlier this month gave its OK to the first new Alzheimer’s drug in years — despite its own panel voting 10-1 against approval. Now, some doctors and hospitals areContinue Reading

Here’s some of HealthDay’s top stories for Thursday, July 22: Two-dose Pfizer vaccine gives great protection against Delta. A new study should reassure millions of Americans who’ve gotten the Pfizer vaccine: Two doses provide 88% protection against the COVID Delta variant. But protection fell sharply for those with only oneContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — A proposed $26 billion settlement on opioid-related lawsuits has been reached with four large drug companies, a group of state attorneys general announced Wednesday. If enough states sign on to the deal with the country’s three major drug distributors — Cardinal Health, AmerisourceBergenContinue Reading